Brag House and FibroBiologics Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
Access the interviews in their entirety at:
TBH:https://www.redchip.com/assets/access/tbh_accessFBLG: https://www.redchip.com/assets/access/fblg_access
In an exclusive interview, Lavell Juan Malloy II, CEO and Co-Founder of Brag House, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to discuss how Brag House is redefining brand engagement for Gen Z through its social gaming and data-driven platform. Malloy highlights the Company's unique ability to connect brands with the highly sought-after Gen Z demographic by fusing college sports rivalries, casual gaming, and community-based interaction into a seamless digital experience. With proven success through partnerships with Coca-Cola, McDonald's, the Denver Broncos, and Learfield, Brag House delivers industry-leading engagement metrics-including CPC and CPM rates significantly below industry averages. Malloy also outlines the Company's strategic alliance with Learfield, powering Brag's national expansion across over 200+ universities, and shares insights into Brag's multi-tiered monetization model and scalable B2B data solutions-positioning the Company at the convergence of three massive markets: gaming, advertising, and analytics.
Pete O'Heeron, CEO of FibroBiologics, appears on the RedChip Small Stocks Big Money™ show on Bloomberg TV to spotlight the company's pioneering work in fibroblast-based cell therapies. O'Heeron discusses the advantages of fibroblasts over traditional stem cells, highlighting their regenerative and immunomodulatory properties, scalability, and safety profile. He outlines the Company's robust pipeline, led by CYWC628 for diabetic foot ulcers, which is slated to enter a Phase 1/2 clinical trial in Australia later this year. Additional programs, including CybroCell™ for degenerative disc disease and CYMS101 for multiple sclerosis, target multi-billion-dollar markets and are supported by promising preclinical and early human data. With over 240 issued and pending patents, a recently completed cGMP-compliant cell bank, and a seasoned leadership team, FibroBiologics is advancing a scalable, off-the-shelf platform poised to transform treatment for chronic diseases and deliver significant long-term value to shareholders.
TBH and FBLG are clients of RedChip Companies. Please read our full disclosure at https://www.redchip.com/legal/disclosures.
About Brag House
Brag House is a leading media technology gaming platform dedicated to transforming casual college gaming into a vibrant, community-driven experience. By seamlessly merging gaming, social interaction, and cutting-edge technology, the Company provides an inclusive and engaging environment for casual gamers while enabling brands to authentically connect with the influential Gen Z demographic. For more information, visit www.braghouse.com.
About FibroBiologics
Based in Houston, FibroBiologics is a clinical-stage biotechnology company developing a pipeline of treatments and seeking potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. FibroBiologics holds 275+ US and internationally issued patents/patents pending across various clinical pathways, including wound healing, multiple sclerosis, disc degeneration, psoriasis, orthopedics, human longevity, and cancer. FibroBiologics represents the next generation of medical advancement in cell therapy and tissue regeneration. For more information, visit www.FibroBiologics.com.
About RedChip Companies
RedChip Companies, an Inc. 5000 company, is an international investor relations, media, and research firm focused on microcap and small-cap companies. For 33 years, RedChip has delivered concrete, measurable results for its clients. Our newsletter, Small Stocks, Big Money™, is delivered online weekly to 60,000 investors. RedChip has developed the most comprehensive service platform in the industry for microcap and small-cap companies. These services include the following: a worldwide distribution network for its stock research; retail and institutional roadshows in major U.S. cities; outbound marketing to stock brokers, RIAs, institutions, and family offices; a digital media investor relations platform that has generated millions of unique investor views; investor webinars and group calls; a television show, Small Stocks, Big Money™, which airs weekly on Bloomberg US; TV commercials in local and national markets; corporate and product videos; website design; and traditional investor relation services, which include press release writing, development of investor presentations, quarterly conference call script writing, strategic consulting, capital raising, and more. RedChip also offers RedChat™, a proprietary AI-powered chatbot that analyzes SEC filings and corporate disclosures for all Nasdaq and NYSE-listed companies, giving investors instant, on-demand insights.
To learn more about RedChip's products and services, please visit:
https://www.redchip.com/corporate/investor_relations
"Discovering Tomorrow's Blue Chips Today"™
Follow RedChip on LinkedIn: https://www.linkedin.com/company/redchip/
Follow RedChip on Facebook: https://www.facebook.com/RedChipCompanies
Follow RedChip on Instagram: https://www.instagram.com/redchipcompanies/
Follow RedChip on Twitter: https://twitter.com/RedChip
Follow RedChip on YouTube: https://www.youtube.com/@redchip
Follow RedChip on Rumble: https://rumble.com/c/c-3068340
Subscribe to our Mailing List: https://www.redchip.com/newsletter/latest
Contact:Dave GentryRedChip Companies Inc.1-407-644-4256info@redchip.com
SOURCE: RedChip Companies, Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
4 hours ago
- Associated Press
LASE Investors Have Opportunity to Join Laser Photonics Corporation Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--Jul 13, 2025-- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Laser Photonics Corporation ('Laser Photonics' or 'the Company') (NASDAQ: LASE ) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Laser Photonics disclosed in a May 29, 2025, SEC filing that it had 'received a notice from Nasdaq Listing Qualifications department of the Nasdaq Stock Market LLC ('Nasdaq') stating that since it had not received the Company's Form 10-Q for the period ended March 31, 2025, and because the Company remains delinquent in filing its Form 10-K for the period ended December 31, 2024 (the 'Initial Delinquent Filing'), the Company does not comply with Nasdaq's Listing Rules for continued listing.' The filing continued, 'the Company has until June 16, 2025, to submit a plan to regain compliance with respect to these delinquent reports.' Based on this news, shares of Laser Photonics fell by more than 6.5% on the next day. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at [email protected]. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. View source version on CONTACT: The Schall Law Firm Brian Schall, Esq. 310-301-3335 [email protected] KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: CLASS ACTION LAWSUIT PROFESSIONAL SERVICES LEGAL SOURCE: The Schall Law Firm Copyright Business Wire 2025. PUB: 07/13/2025 03:36 PM/DISC: 07/13/2025 03:36 PM
Business Insider
4 hours ago
- Business Insider
JPMorgan Says to Short Tesla (TSLA), Moderna (MRNA), and 7 Other Stocks in 2025
JPMorgan (JPM) has released its list of top short ideas for the second half of 2025, spotlighting stocks it believes are positioned to decline in value. The picks span several sectors, including technology, consumer, healthcare, and financials. Among the most notable names are Tesla (TSLA), Moderna (MRNA), Whirlpool (WHR), and Shake Shack (SHAK). Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Nine Stocks JPMorgan Says to Short in H2 2025 Tesla, a $1.01 trillion company, is down around 22% year-to-date. JPMorgan analysts believe its valuation remains elevated relative to the rest of the Magnificent Seven, even with earnings expected to fall for the third consecutive year. Reduced EV subsidies and weak operating margins are part of the concern. There's also skepticism around its robotaxi roadmap, which JPMorgan says lacks sensor redundancy. Meanwhile, Moderna has dropped 19% in 2025 despite a recent bounce of more than 20%. JPMorgan cites continued cash burn, regulatory headwinds, and no clear near-term growth drivers. The firm's analysts do not expect a significant rebound in the stock, though TipRanks data shows an average price target that implies 40% upside. Another notable name is Whirlpool, which is rated Neutral, but JPMorgan sees downside risk following a sharp 38% rally since June. Analyst Michael Rehaut says the stock is trading at a valuation premium of over 15% above its historical averages. While WHR could benefit from U.S. tariffs due to its domestic manufacturing base, Rehaut believes its performance has run ahead of fundamentals. Other stocks on the short list include Shake Shack, which trades at 467 times earnings; Mobileye (MBLY), Intel (INTC), Bumble (BMBL), Comerica (CMA), and Rivian (RIVN). Each carries an Underweight rating from JPMorgan and is flagged for sector-specific challenges or valuation risk. Using TipRanks' Comparison Tool, we've assembled and compared the nine stocks JPM thinks are going to drop. This tool helps you gain a broader perspective on each stock's performance and fundamentals. This list comes at a time when major indexes have bounced back to record highs. The S&P 500 (SPY) and Nasdaq are showing strength, but JPMorgan's cautious picks reflect lingering concern about policy uncertainty and profit outlooks. Investors can track these names closely through TipRanks' analyst consensus, price target forecasts, and Smart Score data to weigh the broader sentiment. As the second half unfolds, JPMorgan's bearish calls offer a watchlist of names where Wall Street sees limited upside and growing risks.
Business Wire
5 hours ago
- Business Wire
PAL Investors Have Opportunity to Join Proficient Auto Logistics, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)-- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Proficient Auto Logistics, Inc. ('Proficient Auto' or 'the Company') (NASDAQ: PAL) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Proficient Auto announced its Q1 financial results on May 7, 2025. The Company suffered a decline in year-over-year total operating revenue as well as reporting a net operating loss. Based on this news, shares of Proficient Auto fell by more than 4.9% on the next day. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at bschall@ The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
